PDB84 - HETEROGENEITY OF TREATMENT EFFECT IN THE DIABETES PREVENTION PROGRAM- HIGH BASELINE RISK OF DEVELOPING DIABETES MAY PROVIDE A PLACE FOR METFORMIN IN DIABETES PREVENTION THAT USING OVERALL SAMPLE AVERAGE COSTS AND EFFECTS CONCEALS
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.789
https://www.valueinhealthjournal.com/article/S1098-3015(18)34089-0/fulltext
Title :
PDB84 - HETEROGENEITY OF TREATMENT EFFECT IN THE DIABETES PREVENTION PROGRAM- HIGH BASELINE RISK OF DEVELOPING DIABETES MAY PROVIDE A PLACE FOR METFORMIN IN DIABETES PREVENTION THAT USING OVERALL SAMPLE AVERAGE COSTS AND EFFECTS CONCEALS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)34089-0&doi=10.1016/j.jval.2018.09.789
First page :
Section Title :
Open access? :
No
Section Order :
188